Orphan drugs for cystic fibrosis and the hereditary rare disease hATTR are on course for European approval after winning the backing of a key regulatory advisory committee. The CHMP’s recommendations ...
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
How Texas is solving the real estate talent gap with these strategies © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results